【24h】

BLUE LIGHT RISK AND LIGHT THERAPY

机译:蓝光风险和光疗法

获取原文

摘要

Light therapy for the treatment of sleepdisorders and jet-lag, as well as for seasonal affective disorder (SAD) has been shown to be effective for many subjects. However, concerns are sometimes expressed about the safety of viewing relatively bright light boxes used in this type of light phototherapy treatment. Typically, a patient is illuminated - normally not on-axis - by an illuminance of approximately 2,500 lux to 10,000 lux as measured at the corneal plane of the eye for periods ranging up to two hours, or even longer each day. Normally there is little ultraviolet radiation from either fluorescent or LED-array light sources. The greatest concerns have centered on the potential retinal hazard from the "blue-light hazard," as described in photobiological lamp safety standards. Currently evaluated, diffused sources do not pose a hazard.
机译:对于治疗困难和喷射滞后以及季节性情感障碍(悲伤)的光疗已被证明对许多受试者有效。然而,有时对在这种类型的光疗法中使用的相对明亮的轻箱的安全性表达了担忧。通常,患者被照亮 - 通常不是轴上 - 通过在眼睛的角膜平面上测量的时间为大约2,500勒克斯到10,000 lux的照明,每天长达两个小时,甚至更长。通常,荧光或LED阵列光源几乎没有紫外线辐射。最令人关切的是,从“蓝光危险”的潜在视网膜危害中,如光生物灯安全标准中所述。目前评估,扩散源不会造成危险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号